ADD/ADHD News

Combined results of a meta-analysis and Swedish population-based study supported a significant link between ADHD and asthma, which remained after controlling for possible confounders.

ADHD is marked by a pattern of inattention and/or hyperactivity-impulsivity that affects daily functioning. According to data from the National Comorbidity Survey Replication, the overall prevalence of adult ADHD in the U.S. is 4.4%, and the estimated lifetime prevalence among those aged 18 to 44 years is 8.1%.

Data published in JAMA revealed that more frequent use of digital media was linked to increased odds of ADHD symptom occurrence over a 2-year period in midadolescence.

Early preterm birth was associated with ADHD in children aged 5 years and inattentive symptoms in children aged 8 years, according to recently published study results in JAMA Pediatrics.

Study findings published in Science indicate many common psychiatric disorders are connected on a genetic level.

Individuals in Denmark who had prior diagnoses of both ADHD and anxiety were 30 times more likely to develop bipolar disorder than those with no prior ADHD or anxiety, according to research findings published in The British Journal of Psychiatry.

Exposure to hypertensive disorders of pregnancy was associated with a small, but statistically significant, rise in offspring’s risk for neurodevelopmental disorders like autism spectrum disorder and ADHD, according to meta-analysis data.

Nonpharmacologic treatment methods used to reduce ADHD symptoms in children 17 years of age and younger, including behavioral modifications, complementary medicines and herbal supplements such as ginkgo biloba, are not supported by data from clinical studies, according to a review published in Pediatrics.

There was an increase of more than 70% in the overall rate of exposures related to ADHD medication reported to U.S. poison control centers between 2000 and 2011, according to recently published study results in Pediatrics.

NEW YORK — Dose-optimized Mydayis, a once-daily mixed salts of a single-entity amphetamine product, improved symptoms and executive function in adults with ADHD with or without sleep-quality impairments at baseline, according to a poster presented here.